Are outcomes of giant ventral hernia repair inferior? A propensity-matched analysis.

Surgical endoscopy 2025 Vol.39(9) p. 6124-6131

Kerr SW, Mead BS, Holland AM, Lorenz WR, Scarola GT, Kercher KW, Augenstein VA, Heniford BT, Ayuso SA

관련 도메인

Abstract

[BACKGROUND] Ventral hernia repair (VHR) of large defects poses significant technical challenges due to the size of the hernia and complexity of operative techniques required for fascial closure. This study examined clinical outcomes in "giant" open VHR (GVHR), with hernia defect size (HDS) ≥ 200 cm, versus "non-giant" open VHR (NGVHR) with HDS < 200 cm using a propensity-matched approach.

[METHODS] A prospectively-maintained database from a tertiary hernia center was reviewed for patients undergoing open VHR. 1:1 propensity-score matching was performed for GVHR versus NGVHR based on age, BMI, comorbidities, fascial defect closure, primary vs recurrent repair, CDC wound class, and ASA score. A multivariable regression model evaluated whether wound complications increased odds of recurrence. CDC class III/IV wounds and concomitant intraabdominal procedures were excluded. Standard statistical analyses were performed.

[RESULTS] PSM yielded 254 well-matched pairs (all p > 0.05). Average age (59.7 ± 11.3 vs. 59.3 ± 12.3 years) and BMI (32.1 ± 6.5 vs. 32.4 ± 6.6 kg/m) were similar between GVHR and NGVHR. Tobacco status was similar for current and former smokers (3.9% vs. 3.9%; 29.9% vs. 29.9%). GVHR had larger defect size (354.7 ± 132.1 vs. 103.8 ± 61.9 cm; p < 0.001) and mesh size (1161.9 ± 450.0 vs. 771.2 ± 388.4 cm; p < 0.001). In GVHR, Botulinum toxin injections (15.4% vs. 2.8%; p < 0.001) and component separation (50.6% vs. 23.7%; p < 0.001) were more frequent. Fascial defect was closed in 100% of both groups (p > 0.999). GVHR had higher rates of wound complications (33.5% vs. 15.4%; p < 0.001), respiratory insufficiency or failure (4.7% vs. 0.8%; p = 0.012), reoperation (9.8% vs. 4.7%; p = 0.028), and greater average length-of-stay (6.9 ± 5.1 vs. 5.0 ± 2.0 days; p < 0.001). There was no statistical difference in recurrence (4.3% vs. 2.4%; p = 0.217) or follow-up (24.0 ± 37.8 vs. 27.4 ± 40.4 months; p = 0.558).

[CONCLUSION] GVHR often required chemical and mechanical component separation to achieve fascial closure. However, with large preperitoneal mesh overlap and fascial closure, outcomes of large defects in VHR are comparable to smaller defects.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 botulinum toxin 보툴리눔독소 주사 dict 1
해부 fascial scispacy 1
합병증 wound scispacy 1
합병증 wounds scispacy 1
약물 [BACKGROUND] Ventral hernia repair scispacy 1
약물 ASA scispacy 1
약물 [RESULTS] PSM scispacy 1
질환 hernia C0019270
Hernia
scispacy 1
질환 GVHR → giant" open VHR scispacy 1
질환 HDS → hernia defect size scispacy 1
질환 respiratory insufficiency C0035229
Respiratory Insufficiency
scispacy 1
기타 VHR → Ventral hernia repair scispacy 1
기타 patients scispacy 1
기타 Tobacco scispacy 1
기타 fascial scispacy 1

MeSH Terms

Humans; Hernia, Ventral; Herniorrhaphy; Middle Aged; Propensity Score; Male; Female; Treatment Outcome; Aged; Recurrence; Retrospective Studies; Postoperative Complications

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문